首页> 外文期刊>Nature Communications >Decreased tumorigenesis in mice with a Kras point mutation at C118
【24h】

Decreased tumorigenesis in mice with a Kras point mutation at C118

机译:C118处具有 Kras 点突变的小鼠的肿瘤发生减少

获取原文
           

摘要

KRAS , NRAS or HRAS genes are mutated to encode an active oncogenic protein in a quarter of human cancers. Redox-dependent reactions can also lead to Ras activation in a manner dependent upon the thiol residue of cysteine 118 (C118). Here, to investigate the effect of mutating this residue on tumorigenesis, we introduce a C118S mutation into the endogenous murine Kras allele and expose the resultant mice to the carcinogen urethane , which induces Kras mutation-positive lung tumours. We report that Kras + / C118S and Kras C118S / C118S mice develop fewer lung tumours. Although the Kras C118S allele does not appear to affect tumorigenesis when the remaining Kras allele is conditionally oncogenic, there is a moderate imbalance of oncogenic mutations favouring the native Kras allele in tumours from Kras + / C118S mice treated with urethane . We conclude that the Kras C118S allele impedes urethane -induced lung tumorigenesis.
机译:在四分之一的人类癌症中,将KRAS,NRAS或HRAS基因突变以编码一种活性致癌蛋白。氧化还原依赖性反应还可以以依赖于半胱氨酸118(C118)的硫醇残基的方式导致Ras活化。在这里,为了研究突变此残基对肿瘤发生的影响,我们将C118S突变引入内源性鼠类Kras等位基因,并将所得小鼠暴露于致癌物氨基甲酸酯中,后者诱发Kras突变阳性的肺肿瘤。我们报告说Kras + / C118S 和Kras C118S / C118S 小鼠发生的肺肿瘤更少。尽管当剩余的Kras等位基因有条件地致癌时,Kras C118S 等位基因似乎不影响肿瘤发生,但是在Kras + / C118S的肿瘤中存在适度的致癌突变失衡,有利于天然Kras等位基因氨基甲酸酯治疗的小鼠。我们得出的结论是,Kras C118S 等位基因阻碍了尿烷诱导的肺肿瘤发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号